Hero

Celyad Announces Registration of the First Hematologic Cancer Patient in CAR-T NKR-2 THINK Trial

1

Celyad Announces Registration of the First Hematologic Cancer Patient in CAR-T NKR-2 THINK Trial

Developing breakthrough pioneering therapies for life-threatening diseases

2

Developing breakthrough pioneering therapies for life-threatening diseases

Directing a weaponized attack on cancer with the NKR-T cell immunotherapy

3

Directing a weaponized attack on cancer with the NKR-T cell immunotherapy

USPTO Decides to Uphold US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

4

USPTO Decides to Uphold US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

About Celyad

Driven by a passion to invent

Celyad is a clinical-stage biopharmaceutical company focused on the discovery and development of breakthrough pioneering cell-based therapies for life-threatening diseases.

More info about Celyad

Latest News

Christian Homsy talked about Celyad on Antipode radio!

Christian Homsy talked about Celyad on Antipode radio!

Celyad retains Piper Jaffray & Co. to explore strategic alternatives relating to its C-Cure® cardiovascular assets

Celyad retains Piper Jaffray & Co. to explore strategic alternatives relating to its C-Cure® cardiovascular assets

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Discover all news

Carousel

Social Feed

https://t.co/aRM0ZiGT3B

2 days ago

https://t.co/aRM0ZiGT3B

10 open positions @CelyadSA Ready to take up the challenge? #clinical #supplychain #manufacturing #IR #QC #QA #jobs https://t.co/0yrWecdhT3

2 days ago

10 open positions @CelyadSA Ready to take up the challenge? #clinical #supplychain #manufacturing #IR #QC #QA #jobs https://t.co/0yrWecdhT3

https://t.co/2anfJr2Imm

2 days ago

https://t.co/2anfJr2Imm

There are currently 10 positions open at Celyad! We are a fast-growing company which is building a talented and dedicated team to bring pioneering breakthrough therapies to patients with life-threatening diseases. Ready to take up this challenge? We are looking forward to receiving your application! https://lnkd.in/gTBfKf4

2 days ago

There are currently 10 positions open at Celyad! We are a fast-growing company which is building a talented and dedicated team to bring pioneering breakthrough therapies to patients with life-threatening diseases. Ready to take up this challenge? We are looking forward to receiving your application! https://lnkd.in/gTBfKf4

https://t.co/aRM0ZiGT3B

2 days ago

https://t.co/aRM0ZiGT3B

10 open positions @CelyadSA Ready to take up the challenge? #clinical #supplychain #manufacturing #IR #QC #QA #jobs https://t.co/0yrWecdhT3

2 days ago

10 open positions @CelyadSA Ready to take up the challenge? #clinical #supplychain #manufacturing #IR #QC #QA #jobs https://t.co/0yrWecdhT3

https://t.co/2anfJr2Imm

2 days ago

https://t.co/2anfJr2Imm

VIDEO @CelyadSA Meeting the #CellTherapy Cost Challenge with #automation #Manufacturing #Phacilitate2017 @Invetech https://t.co/nQ9R0bNX0y

3 days ago

VIDEO @CelyadSA Meeting the #CellTherapy Cost Challenge with #automation #Manufacturing #Phacilitate2017 @Invetech https://t.co/nQ9R0bNX0y

There are currently 10 positions open at Celyad! We are a fast-growing company which is building a talented and dedicated team to bring pioneering breakthrough therapies to patients with life-threatening diseases. Ready to take up this challenge? We are looking forward to receiving your application! https://lnkd.in/gTBfKf4

2 days ago

There are currently 10 positions open at Celyad! We are a fast-growing company which is building a talented and dedicated team to bring pioneering breakthrough therapies to patients with life-threatening diseases. Ready to take up this challenge? We are looking forward to receiving your application! https://lnkd.in/gTBfKf4

Phacilitate2017-Quote-Dieter-Hauwaerts-VP-Operations-Celyad-170221.jpg

3 days ago

Phacilitate2017-Quote-Dieter-Hauwaerts-VP-Operations-Celyad-170221.jpg

Meeting the Cell Therapy Cost Challenge with Automation

3 days ago

Meeting the Cell Therapy Cost Challenge with Automation

Belgian CAR-T biotech enrols first blood cancer patient in new trial

3 days ago

Belgian CAR-T biotech enrols first blood cancer patient in new trial